M. Català

First name

M.

Last name

Català

Barclay, N. L., Català, M., Jödicke, A. M., Prieto-Alhambra, D., Newby, D., Delmestri, A., et al. (2024). Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study. Ther Adv Med Oncol, 16, 17588359241253115. http://doi.org/10.1177/17588359241253115

View

Català, M., Mercadé-Besora, N., Kolde, R., Trinh, N. T. H., Roel, E., Burn, E., et al. (2024). The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med, 12, 225-236. http://doi.org/10.1016/s2213-2600(23)00414-9

View

Català, M., Mercadé-Besora, N., Kolde, R., Trinh, N. T. H., Roel, E., Burn, E., et al. (2024). The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med. http://doi.org/10.1016/s2213-2600(23)00414-9

View

Català, M., Burn, E., Rathod-Mistry, T., Xie, J., Delmestri, A., Prieto-Alhambra, D., & Jödicke, A. M. (2023). Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation. Int J Epidemiol. http://doi.org/10.1093/ije/dyad138

View

Raventós, B., Català, M., Du, M., Guo, Y., Black, A., Inberg, G., et al. (2023). IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5717

View